Submission Details
| 510(k) Number | K915870 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 31, 1991 |
| Decision Date | March 23, 1992 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Statement |
K915870 is an FDA 510(k) clearance for the OPUS RUBELLA TEST SYSTEM, a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II — Special Controls, product code LFX), submitted by Pb Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on March 23, 1992, 83 days after receiving the submission on December 31, 1991. This device falls under the Pathology review panel. Regulated under 21 CFR 866.3510.
| 510(k) Number | K915870 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 31, 1991 |
| Decision Date | March 23, 1992 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Statement |
| Product Code | LFX — Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3510 |